Oncogenic Signalling through Mechanistic Target of Rapamycin (mTOR): A Driver of Metabolic Transformation and Cancer Progression
出版年份 2018 全文链接
标题
Oncogenic Signalling through Mechanistic Target of Rapamycin (mTOR): A Driver of Metabolic Transformation and Cancer Progression
作者
关键词
-
出版物
Cancers
Volume 10, Issue 1, Pages 5
出版商
MDPI AG
发表日期
2018-01-04
DOI
10.3390/cancers10010005
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- mTOR inhibitors in the pharmacologic management of tuberous sclerosis complex and their potential role in other rare neurodevelopmental disorders
- (2017) David N. Franz et al. Orphanet Journal of Rare Diseases
- Inhibition of mTORC2 component RICTOR impairs tumor growth in pancreatic cancer models
- (2017) Katharina M. Schmidt et al. Oncotarget
- Heterogeneous nuclear ribonucleoprotein M associates with mTORC2 and regulates muscle differentiation
- (2017) Wei-Yen Chen et al. Scientific Reports
- mTORC1 Balances Cellular Amino Acid Supply with Demand for Protein Synthesis through Post-transcriptional Control of ATF4
- (2017) Yeonwoo Park et al. Cell Reports
- The Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and Aging
- (2016) Brian K. Kennedy et al. Cell Metabolism
- Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor
- (2016) Vanessa S. Rodrik-Outmezguine et al. NATURE
- mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle
- (2016) I. Ben-Sahra et al. SCIENCE
- TORC2 Structure and Function
- (2016) Christl Gaubitz et al. TRENDS IN BIOCHEMICAL SCIENCES
- DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis
- (2016) Yan-Mei Ji et al. Oncotarget
- Metabolic regulation of natural killer cells: Figure 1
- (2015) David K. Finlay BIOCHEMICAL SOCIETY TRANSACTIONS
- Signalling to eIF4E in cancer
- (2015) N. Siddiqui et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- The miR-491-3p/mTORC2/FOXO1 regulatory loop modulates chemo-sensitivity in human tongue cancer
- (2015) Guopei Zheng et al. Oncotarget
- Selective targeting of human colon cancer stem-like cells by the mTOR inhibitor Torin-1
- (2015) Maria Giovanna Francipane et al. Oncotarget
- Multiple regulation pathways and pivotal biological functions of STAT3 in cancer
- (2015) Jie Yuan et al. Scientific Reports
- Identification of HnRNP M as a novel biomarker for colorectal carcinoma by quantitative proteomics
- (2014) Shuijiao Chen et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Cell type-restricted activity of hnRNPM promotes breast cancer metastasis via regulating alternative splicing
- (2014) Y. Xu et al. GENES & DEVELOPMENT
- MLN0128, an ATP-Competitive mTOR Kinase Inhibitor with Potent In Vitro and In Vivo Antitumor Activity, as Potential Therapy for Bone and Soft-Tissue Sarcoma
- (2014) E. K. Slotkin et al. MOLECULAR CANCER THERAPEUTICS
- The AGC kinase SGK1 regulates TH1 and TH2 differentiation downstream of the mTORC2 complex
- (2014) Emily B Heikamp et al. NATURE IMMUNOLOGY
- Making new contacts: the mTOR network in metabolism and signalling crosstalk
- (2014) Mitsugu Shimobayashi et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- mTORC1 drives HIF-1α and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3
- (2014) K M Dodd et al. ONCOGENE
- mTORC1 signaling controls multiple steps in ribosome biogenesis
- (2014) Valentina Iadevaia et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- mTOR and autophagy: A dynamic relationship governed by nutrients and energy
- (2014) E.A. Dunlop et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer
- (2014) Roland Nilsson et al. Nature Communications
- Elevated SGK1 predicts resistance of breast cancer cells to Akt inhibitors
- (2013) Eeva M. Sommer et al. BIOCHEMICAL JOURNAL
- Integrated molecular analysis of clear-cell renal cell carcinoma
- (2013) Yusuke Sato et al. NATURE GENETICS
- Ribosomal protein S6 kinase activity controls the ribosome biogenesis transcriptional program
- (2013) C Chauvin et al. ONCOGENE
- mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy
- (2013) M. Weiler et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Stimulation of de Novo Pyrimidine Synthesis by Growth Signaling Through mTOR and S6K1
- (2013) I. Ben-Sahra et al. SCIENCE
- Quantitative Phosphoproteomics Reveal mTORC1 Activates de Novo Pyrimidine Synthesis
- (2013) A. M. Robitaille et al. SCIENCE
- Serum and glucocorticoid-regulated kinase 1 (SGK1) activation in breast cancer: requirement for mTORC1 activity associates with ER-alpha expression
- (2012) Ben A. Hall et al. BREAST CANCER RESEARCH AND TREATMENT
- TBC1D7 Is a Third Subunit of the TSC1-TSC2 Complex Upstream of mTORC1
- (2012) Christian C. Dibble et al. MOLECULAR CELL
- The translational landscape of mTOR signalling steers cancer initiation and metastasis
- (2012) Andrew C. Hsieh et al. NATURE
- Emerging Treatments in the Management of Tuberous Sclerosis Complex
- (2012) Michael H. Kohrman PEDIATRIC NEUROLOGY
- Principles of Translational Control: An Overview
- (2012) J. W. B. Hershey et al. Cold Spring Harbor Perspectives in Biology
- Protor-1 is required for efficient mTORC2-mediated activation of SGK1 in the kidney
- (2011) Laura R. Pearce et al. BIOCHEMICAL JOURNAL
- mTOR binds to the promoters of RNA polymerase I- and III-transcribed genes
- (2011) Chi Kwan Tsang et al. CELL CYCLE
- Akt Stimulates Hepatic SREBP1c and Lipogenesis through Parallel mTORC1-Dependent and Independent Pathways
- (2011) Jessica L. Yecies et al. Cell Metabolism
- Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study
- (2011) E. Calvo et al. EUROPEAN JOURNAL OF CANCER
- mSIN1 Protein Mediates SGK1 Protein Interaction with mTORC2 Protein Complex and Is Required for Selective Activation of the Epithelial Sodium Channel
- (2011) Ming Lu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Androgen Receptor Enhances p27 Degradation in Prostate Cancer Cells through Rapid and Selective TORC2 Activation
- (2011) Zi Fang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Relieving Autophagy and 4EBP1 from Rapamycin Resistance
- (2011) B. Nyfeler et al. MOLECULAR AND CELLULAR BIOLOGY
- A Systematic Study of Gene Mutations in Urothelial Carcinoma; Inactivating Mutations in TSC2 and PIK3R1
- (2011) Gottfrid Sjödahl et al. PLoS One
- DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
- (2011) Y. Jiao et al. SCIENCE
- Mammalian target of rapamycin and head and neck squamous cell carcinoma
- (2011) Yu-Min Liao et al. Head and Neck Optical Diagnostics Society
- Phospholipase D stabilizes HDM2 through an mTORC2/SGK1 pathway
- (2010) Donggon Lyo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Requirement of the mTOR Kinase for the Regulation of Maf1 Phosphorylation and Control of RNA Polymerase III-dependent Transcription in Cancer Cells
- (2010) Boris Shor et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Rictor Forms a Complex with Cullin-1 to Promote SGK1 Ubiquitination and Destruction
- (2010) Daming Gao et al. MOLECULAR CELL
- Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1
- (2010) Katrin Düvel et al. MOLECULAR CELL
- COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
- (2010) S. A. Forbes et al. NUCLEIC ACIDS RESEARCH
- Accelerated Wound Healing by mTOR Activation in Genetically Defined Mouse Models
- (2010) Cristiane H. Squarize et al. PLoS One
- Rapamycin inhibits mTORC1, but not completely
- (2009) Carson C. Thoreen et al. Autophagy
- Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR)
- (2009) Juan M. García-Martínez et al. BIOCHEMICAL JOURNAL
- Inflammation and Cancer: IL-6 and STAT3 Complete the Link
- (2009) Jacqueline Bromberg et al. CANCER CELL
- AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with In vitro and In vivo Antitumor Activity
- (2009) C. M. Chresta et al. CANCER RESEARCH
- DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival
- (2009) Timothy R. Peterson et al. CELL
- Mammalian target of rapamycin complex 1: Signalling inputs, substrates and feedback mechanisms
- (2009) E.A. Dunlop et al. CELLULAR SIGNALLING
- Spectrum of Phosphatidylinositol 3-Kinase Pathway Gene Alterations in Bladder Cancer
- (2009) F. M. Platt et al. CLINICAL CANCER RESEARCH
- Characterization of Rictor Phosphorylation Sites Reveals Direct Regulation of mTOR Complex 2 by S6K1
- (2009) C. C. Dibble et al. MOLECULAR AND CELLULAR BIOLOGY
- mTORC1-Activated S6K1 Phosphorylates Rictor on Threonine 1135 and Regulates mTORC2 Signaling
- (2009) L.-A. Julien et al. MOLECULAR AND CELLULAR BIOLOGY
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1)
- (2008) Juan M. García-Martínez et al. BIOCHEMICAL JOURNAL
- Oncogenic MAPK Signaling Stimulates mTORC1 Activity by Promoting RSK-Mediated Raptor Phosphorylation
- (2008) Audrey Carrière et al. CURRENT BIOLOGY
- Role of mTOR in anticancer drug resistance: Perspectives for improved drug treatment
- (2008) Bing-Hua Jiang et al. DRUG RESISTANCE UPDATES
- mTOR-Raptor Binds and Activates SGK1 to Regulate p27 Phosphorylation
- (2008) Feng Hong et al. MOLECULAR CELL
- PTEN: a new guardian of the genome
- (2008) Y Yin et al. ONCOGENE
- Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation
- (2008) A. Y. Choo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Temsirolimus in Renal Cell Carcinoma
- (2008) T. Otto et al. TRANSPLANTATION PROCEEDINGS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More